Experience Leucine AI.
Powered Pharma Operations

Transform Your Pharma Operations with AI-Powered Intelligence. Experience how Leucine's integrated platform brings together manufacturing, quality, and laboratory operations in one digital ecosystem. Schedule a personalized demo to see how our AI solutions can optimize your processes, ensure compliance, and drive operational excellence.

See How AI Transforms Your Shop Floor Operations.
Experience firsthand how Leucine's 10x MES digitalizes batch records, streamlines production, and provides real-time monitoring of your manufacturing operations. Schedule a personalized demo to discover how our AI-powered platform can enhance your productivity while maintaining compliance.

Experience AI-Driven Quality Management in Action.
See how Leucine's 10x QMS automates compliance workflows, streamlines change control, and ensures regulatory adherence. Schedule a demo to learn how our AI-powered platform can help you manage quality processes more efficiently while reducing compliance risks.

Discover Smart Laboratory Operations Management.
Watch how Leucine's 10x LES orchestrates your lab operations, automates documentation, and ensures data integrity. Schedule a demo to see how our AI-powered platform can accelerate your testing processes while maintaining audit-readiness.

Optimize your manufacturing processes with paperless operations
Strengthen quality management and regulatory compliance
Accelerate laboratory operations and testing workflows

Connect with a Leucine Expert

Schedule a 30-Minute Product Demo with Expert Q&A

Blogs

Viable Air Sampling vs Non-Viable Monitoring: A Practical Comparison

Learn effective strategies for optimizing air sampling in cleanrooms to ensure compliance and enhance quality. Dive into the article for practical insights.

Written By
Vivek Gera
Reading Time
8
Minutes
Automate SOP enforcement, residue tracking, and documentation with CLEEN's all-in-one platform.
Back to the Top

In the controlled world of pharmaceutical manufacturing, clean doesn’t always mean sterile—and sterile doesn’t always mean safe.

Despite pristine surfaces, validated HVAC systems, and well-trained operators, contamination can still occur. Not because of visible dirt, but because of invisible elements in the air—some alive, some inert, all capable of compromising product safety, with product sterility being a critical concern.

Gain complete control over your environment with real-time monitoring Stay audit-ready, prevent costly downtimes, and meet global compliance standards with precision. leucine Products


This is where viable and non-viable environmental monitoring step in—not as regulatory burdens, but as essential tools for risk management, batch assurance, and patient safety, especially in pharmaceuticals and other industries that depend on strict contamination control.

Let’s explore how these two distinct monitoring methods work, why both matter, and what leaders need to do today to build smarter, more compliant cleanroom environments, the primary setting for pharmaceutical manufacturing and other high-stakes industries.

VIABLE VS NON-VIABLE MONITORING

Understanding the Contaminants We Monitor

Environmental contaminants fall into two broad categories: contaminants are classified as either viable or non-viable, depending on their origin and potential to cause microbial contamination.

  1. Viable particles: These are living microorganisms such as bacteria, fungi, and spores that can multiply and pose a risk to product sterility.
  2. Non-viable particles: These are inert particles, such as dust, fibers, or skin flakes, that do not contain living organisms but can carry viable contaminants. Non-viable particles are typically measured in cleanrooms at sizes ≥0.5µm and ≥5.0µm. Monitoring different particle sizes is crucial, as various particle size ranges can impact microbial contamination risk and compliance with GMP regulations.

Understanding the distinction between viable and non-viable contaminants is essential for effective cleanroom risk management, as each contaminant type plays a specific role in overall contamination control.

1. Viable Particles – Living microorganisms like bacteria, fungi, and yeast that can grow and reproduce under favorable conditions. These are monitored via viable air sampling and surface methods like contact plates and swabs.

2. Non-Viable Particles – Inert particulate matter such as dust, fibers, and aerosols. These may not be alive, but they are critical because they can carry viable organisms or disrupt airflow, indirectly contributing to contamination.

Both play a role in cleanroom risk—and both require specific monitoring strategies. Non-viable particles include dust, fibers, aerosols, and skin cells, which can originate from people, materials, or the environment. These particles can disrupt airflow and, along with equipment, act as sources of non-viable contamination. Additionally, manufacturing processes such as filling, transferring, and mixing can generate non-viable particles, making their control essential for maintaining cleanroom standards.

Methods of Monitoring: Instruments and Implementation

Viable Air Sampling

This method involves collecting airborne microbes using active air samplers, where samples are obtained by impacting air on agar plates. Post incubation (20–25°C and 30–35°C for up to 72 hours), colonies are counted in colony-forming units (CFU). The results are then evaluated to ensure compliance with regulatory and cleanliness standards.

Key considerations:

  • Sample locations are selected based on airflow studies
  • Plate exposure times are defined per SOPs
  • Incubation tracking must meet stringent compliance norms

Proper interpretation of viable air sampling data is essential for meeting regulatory requirements and maintaining environmental control in cleanroom settings.

Viable Air Sampling vs Non-viable Monitoring A Practical Comparison

Non Viable Particle Counting (NVPC)

Using laser-based particle counters (particle counter technology utilizing light scattering), NVPC instantly quantifies particles ≥0.5µm and ≥5.0µm. Real time data from these instruments is crucial for continuous monitoring and immediate verification of cleanroom standards. These readings inform cleanroom classification (ISO 14644-1), validate airflow integrity, and identify mechanical issues like filter leaks.

Common parameters monitored:

  • Particles per cubic meter
  • Non viable particle count
  • Non viable particle counts
  • Continuous or periodic sampling
  • Action levels per room grade

Zero counts during testing indicate optimal cleanliness and are significant for compliance validation.

Values set by ISO standards define acceptable non viable particle counts, and data analysis of collected results is essential for identifying trends, ensuring compliance, and informing remediation strategies.

Download the Ultimate Environmental Monitoring Checklist Ensure you meet FDA, EMA, and ISO standards with a structured, risk-based monitoring approach. Download Leucine Audit Readiness Checklist

Regulatory Expectations and Monitoring Limits

Authorities such as FDA, EU GMP, and USP mandate strict limits and trend monitoring. Compliance with established guidelines and regulations, such as ISO 14644, is essential to ensure proper control of airborne particles in cleanroom and pharmaceutical environments. A breach in either viable or non-viable thresholds must be recorded, investigated, and closed with documented CAPA, and facilities must respond promptly to such deviations.

Cleanroom Grade
Viable Particle Count Limit (CFU/m³)
≥0.5µm Particles/m³ (NVPC Limit)
Grade A
0
3,520
Grade B
≤10
35,200
Grade C
≤100
352,000
Grade D
≤200
3,520,000


These limits are based on ISO class standards and cleanroom classifications, which define cleanliness levels according to allowable particle counts.

Action and alert limits are derived from guidelines and empirical data, and their frequency of exceedance is monitored to ensure ongoing compliance. It is important to determine when a breach of these limits requires a response to maintain product safety and environmental control.

Use Cases: Where and When Each Monitoring Type Excels

Viable monitoring is essential during aseptic filling, in high-risk zones (Grade A/B), and where human intervention is high within controlled environments and associated controlled environments. Monitoring is also critical in a surgical suite, where maintaining a sterile environment is vital to prevent contamination and reduce infection risk. It’s the only way to confirm microbial presence.

Non-viable monitoring is more continuous and ideal for HVAC validation, airflow pattern analysis, and real-time environmental control. Maintaining a cleanroom environment is crucial for ensuring compliance with ISO standards and protecting product sterility.

In practice, the two methods work together:

  • Viable monitoring confirms biological contamination
  • NVPC offers predictive control of cleanroom dynamics
  • Viable particle monitoring detects microbial contamination when present, and the absence of contamination is a positive outcome for controlled environments

Observation and routine monitoring play a key role in ensuring compliance and early detection of potential contamination issues.

Strategic View: Environmental Monitoring and Assessment

The Pitfalls of a Fragmented Monitoring Program

Many facilities still operate with manual data entry, delayed incubation logs, or siloed NVPC records. This results in:

  • Missed sampling points
  • Untrended NVPC deviations
  • Increased risk of false alarms when alert thresholds are not set appropriately, leading to unnecessary investigations and potential oversight of true contamination events
  • Delayed microbial recovery alerts
  • Gaps in audit readiness

These challenges aren’t theoretical. In 2024, several Form 483s were issued for:

  • “Failure to investigate CFU recovery above alert limits”
  • “No trending of NVPC data over multiple months”
  • “Missing incubation documentation for active air samples”

Proper monitoring requires setting appropriate alert limits and action limits as critical parameters. Using correct values for non-viable particle counts and exercising careful consideration in monitoring program design are essential to ensure regulatory compliance and effective contamination control.

Get Detailed Breakdown: Top 483 Observations on FDA Environmental Monitoring
VIABLE VS NON-VIABLE MONITORING key differences

The Role of Automation and Intelligence in Modern EM

Enter Leucine’s AI-Driven Environmental Monitoring System—a platform built not just to monitor, but to predict, optimize, and defend your cleanroom operations. With advanced AI-driven solutions, it addresses the challenges of modern environmental monitoring, ensuring compliance and optimal performance for cleanroom environments.

Gain complete control over your environment with real-time monitoring Stay audit-ready, prevent costly downtimes, and meet global compliance standards with precision. leucine Products

Here’s how it elevates both viable and non-viable monitoring:

✅ Smart Sampling Compliance

AI auto-generates sampling plans, ensuring 100% adherence with zero human error.

✅ Incubation & CFU Detection Automation

Incubation schedules, exposure durations, and CFU reading workflows are digitized and validated, eliminating guesswork.

✅ Real-Time Deviation Handling

The system detects, flags, and escalates anomalies instantly—whether from viable or non-viable inputs.

✅ Predictive Analytics

Get actionable insights with AI-powered heatmaps, microbial trend tracking, and batch impact assessments.

✅ Regulatory Audit Readiness

21 CFR Part 11 compliant, with full audit trails, e-signatures, and deviation logs.

Schedule a Personalized Demo

Looking Ahead: Integrated, Intelligent Monitoring Is No Longer Optional

In conclusion, as global regulatory scrutiny rises and product complexity grows, traditional EM systems—rooted in paper logs and reactive responses—simply won’t suffice.

A forward-thinking monitoring program:

  • Treats viable and non-viable monitoring as one ecosystem
  • Uses real-time analytics to detect contamination early
  • Prepares you for audits before they’re even scheduled
  • Enables cross-functional visibility—from Quality to Manufacturing

Looking ahead, controlling humidity and unidirectional airflow will be essential in future cleanroom manufacture practices to maintain aseptic conditions and meet regulatory standards.

It’s not about choosing between viable air sampling or NVPC in pharma—it’s about leveraging both, intelligently, to elevate compliance, ensure safety, and protect your reputation.

Talk to our experts

Back to LES Hub
Viable Air Sampling vs Non-Viable Monitoring: A Practical Comparison

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Dive Deep into the Following Critical Aspects

Documentation

Ensure EM records are complete, audit-trailed, and compliant with regulatory expectations.

Process and System Review

Assess the effectiveness of monitoring protocols, validations, and SOPs.

Regulatory Compliance

Stay aligned with FDA, EMA, WHO, and global EM guidelines for 2025.

Facility & Personnel

Evaluate cleanroom controls and ensure staff are trained on aseptic practices.

Communication and Coordination

Improve cross-functional collaboration to resolve EM deviations swiftly.

Follow-up and Monitoring

Track trends, escalate deviations, and ensure timely CAPA implementation.

Back to LES Hub
Viable Air Sampling vs Non-Viable Monitoring: A Practical Comparison

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Dive Deep into the Following Critical Aspects

Documentation

Ensure Environmental Monitoring records are complete, audit-trailed, and compliant with regulatory expectations.

Process and System Review

Assess the effectiveness of monitoring protocols, validations, and SOPs.

Regulatory Compliance

Stay aligned with FDA, EMA, WHO, and global EM guidelines for 2025

Facility & Personnel

Evaluate cleanroom controls and ensure staff are trained on aseptic practices.

Communication and Coordination

Improve cross-functional collaboration to resolve EM deviations swiftly.

Follow-up and Monitoring

Track trends, escalate deviations, and ensure timely CAPA implementation.

Experience AI-Powered Environmental Monitoring with Leucine
Join leading pharmaceutical companies in transforming batch execution with electronic batch record (EBR) software. Ensure GMP compliance, reduce deviations, and accelerate batch release—all with one intelligent solution.